Arcellx Inc

Arcellx insider trading recap: CMO Heery Christopher’s RSU vesting and tax‑sell moves reveal routine liquidity steps, not speculative bets, while positive sentiment and a 7.6% weekly surge hint at investor confidence in the biotech’s Phase II pipeli…

Arcellx insider sale analysis: Christopher’s recent 6,131‑share sale at market price signals liquidity management, not a bearish trend, while investors should focus on the company’s adaptive immune therapy pipeline and technology‑driven value‑based …